Active	Status	Sponsor type	Region	Phase	Filter
5 Active 10 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Francis, Darrel
ORBITA-2, NCT03742050: A Placebo-controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina	Completed	N/A	439	Europe	Percutaneous coronary intervention, Coronary angioplasty	Imperial College London, Basildon and Thurrock Hospitals NHS FoundationTrust	Stable Angina	09/23	09/23
Crespo, Patricia Gomez
SURPASS-2, NCT04752358 / 2020-005802-24: ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers	Terminated	2	3	Europe, Canada, US	Autologous genetically modified ADP-A2M4CD8 cells	Adaptimmune, ICON plc	Esophageal Cancer, Esophagogastric Junction Cancer	06/23	12/23
MIDI, NCT04368481: (MR Imaging Abnormality Deep Learning Identification)	Recruiting	N/A	30000	Europe		King's College Hospital NHS Trust, King's College London	Neurological Disorder	08/24	03/25
Sallomi, David
MIDI, NCT04368481: (MR Imaging Abnormality Deep Learning Identification)	Recruiting	N/A	30000	Europe		King's College Hospital NHS Trust, King's College London	Neurological Disorder	08/24	03/25
Boxall, Penny
MIDI, NCT04368481: (MR Imaging Abnormality Deep Learning Identification)	Recruiting	N/A	30000	Europe		King's College Hospital NHS Trust, King's College London	Neurological Disorder	08/24	03/25